Updates in endoscopic bariatric and metabolic therapies.
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The rising prevalence of obesity, and related morbidity and mortality, has necessitated the development of therapeutic weight loss strategies. Lifestyle modifications alone have only yielded modest benefit, and while bariatric surgery has shown significant short- and long-term results, only a minority of eligible patients end up receiving this treatment. Endoscopic bariatric and metabolic therapies (EBMTs) are a rapidly evolving field, which provides a less invasive middle ground treatment option for weight loss. Here we discuss the efficacy, as well as short- and long-term outcomes with restrictive, malabsorptive/metabolic and aspiration endoscopic techniques, and their effects on metabolic parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse effects include nausea/vomiting (20%) and abdominal pain (7%).118”
From Obesity Management in Adults: A Review (2023) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O’Brien, P. E., Hindle, A., Brennan, L., Skinner, S., Burton, P., Smith, A., Crosthwaite, G., & Brown, W. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3525-0 · Cited by 815 · cited 1×
“The EBMT procedures can largely be subdivided into restrictive, malabsorptive/metabolic and aspiration techniques depending on their target [8].”
BackgroundPeterli, R., Steinert, R. E., Woelnerhanssen, B., Peters, T., Christoffel-Courtin, C., Gass, M., Kern, B., von Fluee, M., & Beglinger, C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0622-3 · Cited by 529
Abu Dayyeh, B. K., Kumar, N., Edmundowicz, S. A., Jonnalagadda, S., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1964 · Cited by 469 · cited 3×
“In three randomized controlled trials (RCTs) comparing Orbera balloon placement to controls, % EBWL was 26.9% (95% CI, 15.6 – 38.2; p ≤ 0.01) [7].”
BackgroundMethodInfluentialAssociation of body mass index with health care expenditures in the united states by age and sex
Ward, Z. J., Bleich, S. N., Long, M. W., & Gortmaker, S. L. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247307 · Cited by 428 · cited 1×
“As such, obesity and its complications have been recognized as a public health crisis and concerted efforts targeting development of preventive and treatment strategies is ongoing [2,3].”
BackgroundAbu Dayyeh, B. K., Bazerbachi, F., Vargas, E. J., Sharaiha, R. Z., Thompson, C. C., Thaemert, B. C., Teixeira, A. F., Chapman, C. G., Kumbhari, V., Ujiki, M. B., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01280-6 · Cited by 338 · cited 1×
“All were successfully treated [25].”
Abu Dayyeh, B. K., Acosta, A., Camilleri, M., Mundi, M. S., Rajan, E., Topazian, M. D., & Gostout, C. J. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.030 · Cited by 305
Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis
Hedjoudje, A., Abu Dayyeh, B. K., Cheskin, L. J., Adam, A., Neto, M. G., Badurdeen, D., Morales, J. G., Sartoretto, A., Nava, G. L., Vargas, E., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.022 · Cited by 266 · cited 1×
“The pooled adverse event rate was 2.2% [23].”
BackgroundInfluentialShort-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients
Alqahtani, A., Al-Darwish, A., Mahmoud, A. E., Alqahtani, Y. A., & Elahmedi, M. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.12.012 · Cited by 207 · cited 1×
“These hormonal changes are thought to contribute to a higher weight loss observed with LSG compared to ESG, because even though ESG mimics LSG in terms of anatomic alterations it does not seem to reproduce the same hormonal changes [30,35,36].”
BackgroundThompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.500 · Cited by 201 · cited 2×
“Serious adverse effects are rare, including peritonitis and prepyloric ulceration or tube removal [50].”
Backgroundvan Baar, A. C. G., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., Rodriguez Grunert, L., Galvao Neto, M., Vignolo, P., Hayee, B., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318349 · Cited by 201
Sullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz‐Muñoz, N., Jonnalagadda, S. S., Ujiki, M., Ikramuddin, S., Ponce, J., Ryou, M., et al. (2017) · Obesity · doi:10.1002/oby.21702 · Cited by 179
Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study
Fayad, L., Adam, A., Schweitzer, M., Cheskin, L. J., Ajayi, T., Dunlap, M., Badurdeen, D. S., Hill, C., Paranji, N., Lalezari, S., et al. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.030 · Cited by 175 · cited 2×
“These hormonal changes are thought to contribute to a higher weight loss observed with LSG compared to ESG, because even though ESG mimics LSG in terms of anatomic alterations it does not seem to reproduce the same hormonal changes [30,35,36].”
BackgroundGersin, K. S., Rothstein, R. I., Rosenthal, R. J., Stefanidis, D., Deal, S. E., Kuwada, T. S., Laycock, W., Adrales, G., Vassiliou, M., Szomstein, S., et al. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.11.051 · Cited by 173 · cited 1×
“Side effects were GI bleeding, abdominal pain, nausea and vomiting [59].”
BackgroundMachytka, E., Bužga, M., Zonca, P., Lautz, D. B., Ryou, M., Simonson, D. C., & Thompson, C. C. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.07.009 · Cited by 172 · cited 2×
“Machytka (2017) [60] Pilot RCT IMAS (n = 10) Weight loss by 12 months TBWL = 14.”
BackgroundLee, Y.-M., Low, H. C., Lim, L. G., Dan, Y. Y., Aung, M. O., Cheng, C. L., Wee, A., Lim, S. G., & Ho, K. Y. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.05.023 · Cited by 132
Novikov, A. A., Afaneh, C. I., Saumoy, M., Parra, V., Shukla, A. P., Dakin, G. F., Pomp, A., Dawod, E., Shah, S. M., Aronne, L. J., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3615-7 · Cited by 128 · cited 1×
“In the LAGB group, complications included gastric outlet obstruction, wound infection, abdominal pain, and pulmonary embolism [31].”
BackgroundRohde, U., Hedbäck, N., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12603 · Cited by 124
Bazerbachi, F., Vargas, E. J., Rizk, M., Maselli, D. B., Mounajjed, T., Venkatesh, S. K., Watt, K. D., Port, J. D., Basu, R., Acosta, A., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.068 · Cited by 124
Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years
Dastis, S. N., François, E., Deviere, J. M. E., Hittelet, A., Mehdi, A. I., Barea, M., & Dumonceau, J. (2009) · Endoscopy · doi:10.1055/s-0029-1214826 · Cited by 123 · cited 1×
“While presence of IGB for many months may introduce new alimentary habits, and thus more permanent weight loss, it seems that weight regain is frequently encountered in the months/years after IGB removal [17 – 19].”
BackgroundThe Response of the US Centers for Disease Control and Prevention to the Obesity Epidemic
Dietz, W. H. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122415 · Cited by 118 · cited 3×
“As such, obesity and its complications have been recognized as a public health crisis and concerted efforts targeting development of preventive and treatment strategies is ongoing [2,3].”
BackgroundAbu Dayyeh, B. K., Maselli, D. B., Rapaka, B., Lavin, T., Noar, M., Hussan, H., Chapman, C. G., Popov, V., Jirapinyo, P., Acosta, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02394-1 · Cited by 109 · cited 1×
“Balloon adjustment was required in 80% of patients (intolerance or weight loss plateau), with upward adjustment allowing another 5.2% TBWL. Downward adjustment allowed 75% of patients to complete the full duration of therapy [13].”
BackgroundInfluentialMiller, K., Turró, R., Greve, J. W., Bakker, C. M., Buchwald, J. N., & Espinós, J. C. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2295-9 · Cited by 102
Popov, V. B., Ou, A., Schulman, A. R., & Thompson, C. C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.530 · Cited by 100 · cited 3×
“9 and ≥1 obesity-related comorbidities who have failed medical/lifestyle interventions [9].”
BackgroundHajifathalian, K., Mehta, A., Ang, B., Skaf, D., Shah, S. L., Saumoy, M., Dawod, Q., Dawod, E., Shukla, A., Aronne, L., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.08.023 · Cited by 96
Trang, J., Lee, S. S., Miller, A., Pico, C. X. C., Postoev, A., Ibikunle, I., & Ibikunle, C. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.06.038 · Cited by 93 · cited 1×
“Intragastric balloons can stay in place for about 4–12 months, depending on the type of balloon [6,10].”
BackgroundJirapinyo, P., McCarty, T. R., Dolan, R. D., Shah, R., & Thompson, C. C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.017 · Cited by 86 · cited 2×
“A sustained weight loss of 7–10% TBW is needed to decrease steatohepatitis, steatosis and fibrosis; however, this is often difficult to achieve and sustain [4,5].”
BackgroundResultLópez-Nava, G., Negi, A., Bautista-Castaño, I., Rubio, M. Á., & Asokkumar, R. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04541-0 · Cited by 85 · cited 1×
“These hormonal changes are thought to contribute to a higher weight loss observed with LSG compared to ESG, because even though ESG mimics LSG in terms of anatomic alterations it does not seem to reproduce the same hormonal changes [30,35,36].”
BackgroundThe EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
Ruban, A., Ashrafian, H., & Teare, J. P. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/7823182 · Cited by 76 · cited 3×
“The consequence is that there is a decrease in the production of anti-incretins, which leads to increased incretin production, increased bile acid production as possibly favorable modifications of the gut microbiota [54,55].”
BackgroundNyström, M., Machytka, E., Norén, E., Testoni, P. A., Janssen, I., Turró Homedes, J., Espinos Perez, J. C., & Turro Arau, R. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3096-5 · Cited by 73 · cited 1×
“The goal of this device is to physically remove approximately 30% of an ingested meal [47].”
BackgroundKotinda, A. P. S. T., de Moura, D. T. H., Ribeiro, I. B., Singh, S., Neto, A. M. D. P., Proença, Í. M., Flor, M. M., de Souza, K. L., Bernardo, W. M., & de Moura, E. G. H. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04558-5 · Cited by 73 · cited 2×
“4% decrease in TBWL with intragastric balloons, compared to lifestyle interventions alone [11].”
BackgroundBadurdeen, D., Hoff, A. C., Hedjoudje, A., Adam, A., Itani, M. I., Farha, J., Abbarh, S., Kalloo, A. N., Khashab, M. A., Singh, V. K., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.10.016 · Cited by 72 · cited 1×
“Patients who received the additional medical therapy had a higher mean %TBWL at 7 months after initiation of lirag-lutide compared with those who declined it (24.7% vs. 20.51; p < 0.001), as well as greater reduction in percent body fat (7.85% vs. 10.54%; p < 0.001) at 12 months [39].”
BackgroundInfluentialEfficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis
Li, P., Ma, B., Gong, S., Zhang, X., & Li, W. (2019) · Surgical Endoscopy · doi:10.1007/s00464-019-06889-6 · Cited by 68 · cited 1×
“Similarly, pooled EBWL at 1, 3, 6 and 12 months were 31.16% ( p 0.001), 43.61% ( p 0.001), 53.41% ( p 0.001) and 59.08% ( p = 0.015), respectively [24].”
InfluentialFayad, L., Cheskin, L. J., Adam, A., Badurdeen, D. S., Hill, C., Agnihotri, A., Dunlap, M., Simsek, C., Khashab, M. A., Kalloo, A. N., et al. (2019) · Endoscopy · doi:10.1055/a-0852-3441 · Cited by 66
Huberty, V., Boškoski, I., Bove, V., Ouytsel, P. V., Costamagna, G., Barthet, M. A., & Deviere, J. M. E. (2020) · Gut · doi:10.1136/gutjnl-2020-322026 · Cited by 64
Thompson, C. C., Abu Dayyeh, B. K., Kushnir, V., Kushner, R. F., Jirapinyo, P., Schorr, A. B., Aronne, L. J., Amaro, A., Jaffe, D. L., Schulman, A. R., et al. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.04.026 · Cited by 56 · cited 2×
“The main reasons for discontinuation were fatigue with the therapy or achievement of desired weight loss [48,49].”
BackgroundHuberty, V., Machytka, E., Boškoski, I., Barea, M., Costamagna, G., & Deviere, J. M. E. (2018) · Endoscopy · doi:10.1055/a-0630-1224 · Cited by 55 · cited 2×
“4% at 12 months, with no severe adverse events [45].”
BackgroundSingh, S., Bazarbashi, A. N., Khan, A., Chowdhry, M., Bilal, M., de Moura, D. T. H., Jirapinyo, P., Thakkar, S., & Thompson, C. C. (2022) · Surgical Endoscopy · doi:10.1007/s00464-020-08267-z · Cited by 52 · cited 2×
“Singh (2021) [43] Meta Analysis POSE (n = 613) Weight loss at 3–6 months and 12–15 months.”
BackgroundAGA Technical Review on Intragastric Balloons in the Management of Obesity
Shah, R., Davitkov, P., Dayyeh, B. K. A., Saumoy, M., & Murad, M. H. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.043 · Cited by 52 · cited 2×
“Bariatric surgery, on the other hand, is more invasive but has demonstrated more durability than medical therapies for up to 20 years [6].”
BackgroundJagtap, N., Kalapala, R., Katakwar, A., Sharma, M., Aslam, M., Gupta, R., Rao, P. N., Goud, R., Tandan, M., Kanakagiri, H., et al. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-021-01202-7 · Cited by 43 · cited 1×
“Jagtap (2021) [27] Prospective Cohort ESG (n = 26) Impact of ESG on hepatic parameters, metabolic parameters at 6 and 12 months.”
BackgroundGollisch, K., Lindhorst, A., & Raddatz, D. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-118961 · Cited by 42
Endoscopic sleeve gastroplasty: From whence we came and where we are going
Moura, D. T. H. D., Moura, E. G. H. D., & Thompson, C. C. (2019) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v11.i5.322 · Cited by 39 · cited 1×
“This is thought to increase satiety and delay gastric emptying [21,22].”
BackgroundGu, L., Lin, K., Du, N., Ng, D. M., Lou, D., & Chen, P. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.10.018 · Cited by 37 · cited 1×
“Several studies suggest that LSG leads to changes in GLP-1 (Glucagon-like peptide 1) levels as well as changes in bile acid secretion, improves insulin sensitivity, decreases ghrelin, and improves glucose homeostasis [32 – 34].”
BackgroundIntragastric balloon treatment of obesity: Long-term results and patient satisfaction
Haddad, A. K. E., Rammal, M. O., Soweid, A., Sharara, A. I., Daniel, F. E., Rahal, M., & Shaib, Y. H. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.17877 · Cited by 34 · cited 1×
“While presence of IGB for many months may introduce new alimentary habits, and thus more permanent weight loss, it seems that weight regain is frequently encountered in the months/years after IGB removal [17 – 19].”
BackgroundEffect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis
Jirapinyo, P., de Moura, D. T. H., Horton, L. C., & Thompson, C. C. (2020) · Clinical Endoscopy · doi:10.5946/ce.2019.181 · Cited by 32 · cited 1×
“Jirapinyo (2020) [51] Meta-Analysis Gastric Aspiration Therapy (n = 590) Changes in metabolic comorbidities at 1 yr, weight loss up to 4 yrs.”
MethodJirapinyo, P., & Thompson, C. C. (2018) · VideoGIE · doi:10.1016/j.vgie.2018.08.002 · Cited by 31 · cited 1×
“A new more distal “belt -and- suspenders” POSE approach has been recently proposed [44].”
BackgroundLavín-Alconero, L., Fernández-Lanas, T., Iruzubieta-Coz, P., Arias-Loste, M. T., Rodriguez-Duque, J. C., Rivas, C., Cagigal, M. L., Montalbán, C., Useros, A. L., Álvarez-Cancelo, A., et al. (2021) · Trials · doi:10.1186/s13063-021-05695-7 · Cited by 29
Kozłowska‐Petriczko, K., Pawlak, K. M., Wojciechowska, K., Reiter, A., Błaszczyk, Ł., Szełemej, J., Petriczko, J., & Wiechowska–Kozłowska, A. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06398-x · Cited by 27
Jung, S. H., Yoon, J. H., Choi, H. S., Nam, S., Kim, K. O., Kim, D. H., Kim, J., Sohn, W., Hyun, Y. S., Park, C. H., et al. (2020) · Endoscopy · doi:10.1055/a-1149-1862 · Cited by 25 · cited 1×
“[63].”
Meiring, S., Meessen, E. C. E., van Baar, A. C. G., Holleman, F., Nieuwdorp, M., Damink, S. W. M. O., Schaap, F. G., Vaz, F. M., Groen, A. K., Soeters, M. R., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2021 · Cited by 23 · cited 1×
“It has been hypothesized that ablation of the duodenal mucosa may increase insulin sensitivity and achieve weight loss, potentially via increases in unconjugated and secondary bile acid production [53].”
BackgroundRen, M., Zhou, X., Zhang, Y., Mo, F., Yang, J., Yu, M., & Ji, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931519 · Cited by 22 · cited 2×
“The most common EBMT modalities that were used included IGBs in 19 studies, DMR = 3 studies, endobarrier in 8 studies, ESG in 3 studies, POSE in 1 study and aspiration therapy in 2 studies [4].”
BackgroundMethodEndobariatric procedures for obesity: clinical indications and available options
Goyal, H., Kopel, J. J., Perisetti, A., Mann, R., Ali, A. B., Tharian, B., Saligram, S., & Inamdar, S. (2021) · Therapeutic Advances in Gastrointestinal Endoscopy · doi:10.1177/2631774520984627 · Cited by 17 · cited 1×
“Contraindications to IGB placement include coagulopathy, history of GI tract surgery, GI bleeding and gastric ulcers [9,12,16].”
BackgroundRyder, R. E. J., Yadagiri, M., Burbridge, W., Irwin, S. P., Gandhi, H., Bashir, T., Allden, R. A., WYRES, M. C., CULL, M. L., Bleasdale, J. P., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14827 · Cited by 13
Perspectives toward minimizing the adverse events of endoscopic sleeve gastroplasty
de Moura, D. T. H., Badurdeen, D., Ribeiro, I. B., Leite, E. F. M. D. S. D., Thompson, C. C., & Kumbhari, V. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.06.038 · Cited by 12 · cited 2×
“Previous bariatric surgery is not an absolute contraindication [40].”
BackgroundHollenbach, M., Prettin, C., Gundling, F., Schepp, W., Seufert, J., Stein, J. M., Rösch, T., Aberle, J., Feisthammel, J., Petroff, D., et al. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0838-3 · Cited by 11 · cited 2×
“However, following device explanation only one patient in the intragastric balloon group maintained > 10% TBWL [58].”
BackgroundTechnical aspects of endoscopic sleeve gastroplasty
Barola, S., Chen, Y., Ngamruengphong, S., Kalloo, A. N., Khashab, M. A., & Kumbhari, V. (2017) · VideoGIE · doi:10.1016/j.vgie.2017.01.002 · Cited by 10 · cited 1×
“The procedure utilizes an endoscopic suturing device (OverStitch; Apollo Endosurgery, Austin, TX) to create a small diameter sleeve (tubular lumen) along the lesser curvature, thereby reducing the volume of the stomach by approximately 70% [20].”
MethodGastric mucosal devitalization (GMD): translation to a novel endoscopic metabolic therapy
Fayad, L., Oberbach, A., Schweitzer, M., Askin, F. B., Voltaggio, L., Larman, T., Enderle, M. D., Hahn, H., Khashab, M. A., Kalloo, A. N., et al. (2019) · Endoscopy International Open · doi:10.1055/a-0957-3067 · Cited by 9 · cited 1×
“Hence, some early animal studies suggest that ESG may produce weight loss outcomes similar to LSG if additional therapy, aimed at mimicking the physiologic and hormonal changes seen with LSG, is introduced [37,38].”
BackgroundOberbach, A., Schlichting, N. S., Kullnick, Y., Heinrich, M., Lehmann, S., Retschlag, U., Friedrich, M., Fayad, L., Dietrich, A., Khashab, M. A., et al. (2019) · Endoscopy International Open · doi:10.1055/a-0990-9683 · Cited by 8 · cited 1×
“Hence, some early animal studies suggest that ESG may produce weight loss outcomes similar to LSG if additional therapy, aimed at mimicking the physiologic and hormonal changes seen with LSG, is introduced [37,38].”
BackgroundAre We Moving in the Right Direction by Altering Gastric Motility for Weight Loss?
Sharaiha, R. Z., & Kumbhari, V. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.009 · Cited by 4 · cited 1×
“Several studies suggest that LSG leads to changes in GLP-1 (Glucagon-like peptide 1) levels as well as changes in bile acid secretion, improves insulin sensitivity, decreases ghrelin, and improves glucose homeostasis [32 – 34].”
BackgroundRyder, R. E. J., Yadagiri, M., Burbridge, W., Irwin, S. P., Gandhi, H., Bashir, T., Allden, R. A., WYRES, M. C., CULL, M. L., Bleasdale, J. P., et al. (2022) · Practical Diabetes · doi:10.1002/pdi.2393 · Cited by 4 · cited 1×
“Early removal occurred in 13/90 patients: five for GI bleeding, two for liver abscess and one for intraabdominal abscess [56].”
BackgroundThompson, C. C., Dayyeh, B. K. A., Kushnir, V., Kushner, R. F., Schorr, A. B., Aronne, L. J., Amaro, A., Jaffe, D. L., Schulman, A. R., Early, D., et al. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.09.018 · Cited by 3 · cited 1×
“The main reasons for discontinuation were fatigue with the therapy or achievement of desired weight loss [48,49].”
BackgroundBapaye, J., Chandan, S., Khan, S. R., Mohan, B. P., Ramai, D., Dhindsa, B., Shah, A. R., Saghir, S. M., Bilal, M., & Facciorusso, A. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.04.089 · Cited by 2 · cited 4×
“Balloon-related complications may include balloon overinflation, spontaneous balloon deflation, migration, impaction or balloon valve malfunction [12].”
BackgroundMethodInfluentialLong-Term Maintenance of Weight Loss Following Removal of Intragastric Balloon (IGB)
Pytraczyk, S., & Cohen, L. B. (2018) · The American Journal of Gastroenterology · doi:10.14309/00000434-201810001-00786 · Cited by 1
Hoffmeister, A., Hollenbach, M., Prettin, C., Gundling, F., Schepp, W., Seufert, J., Stein, J. M., Aberle, J., Feisthammel, J., & Petroff, D. (2022) · Endoscopy · doi:10.1055/s-0042-1744676 · Cited by 1
Research works printed but not linked: 1
- Stahl J.M. Malhotra S. Obesity Surgery Indications and Contraindications StatPearls Publishing Treasure Island, FL, USA 2018 30020657
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Nduma, B. N., Mofor, K. A., Tatang, J., Amougou, L., Nkeonye, S., Chineme, P., Ekhator, C., & Ambe, S. (2023) · Cureus · doi:10.7759/cureus.41466 · Cited by 12
“(2023) [17] Whereas the total body weight loss in the ESG group was documented to be lower than that in the LSG group, the rate of adverse events in the ESG group was established to be more promising.”
BackgroundFrom pathophysiology to novel approaches for obesity-associated hypertension
Kanbay, M., Yayci, E., Genc, C., Çöpür, S., Aktaş, Ö. Y., Sarafidis, P. A., Covic, A. C., Ortíz, A., & Laffin, L. J. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf218 · Cited by 11
“Endoscopic gastric plication, gastric aspiration, duodenal mucosal resurfacing, endoscopic anastomosis systems and endoscopic bypass liners are other potential endoscopic bariatric procedures with limited clinical experience [113 ].”
Abaalkhail, F. A., Sanai, F. M., Alswat, K., Alzanbagi, A., Al-Jedai, A. H., Alshehri, A., Alfadda, A. A., Alghamdi, H., Almadi, M. A., AlEissa, M., et al. (2025) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_199_25 · Cited by 12
A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications
Abuawwad, M., Tibude, A., Bansi, D. S., IDRIS, I. R., & Madhok, B. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15613 · Cited by 9
“4,9,48 Nduma et al. published a systematic review of 20 studies confirming a superior safety profile of ESG, including a lower risk of de-novo gastric oesophageal reflux disease (GORD), whereas SG resulted in a higher weight loss and a higher chance of remission of obesity-related comorbidities.”
Background
Metadata
- Authors
- Qureshi, H., Saeed, N., & Jovani, M.
- Affiliations
- University of Kentucky (US)
- Maimonides Medical Center (US)
- Corresponding author
- Jovani, Manol
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 12
- Issue
- 3
- Pages
- 1126
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9917553
- OpenAlex
- W4319795290
- Cited by
- 21
- References
- 64
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 2 · 2023: 4
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- endoscopic bariatric therapy, obesity, weight loss, metabolic parameters, long-term outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.